GHIT Fund Global Health Innovative Technology Fund

Investment

Details

Portfolio

Advancing Portfolio

Screening project between Takeda and MMV

RFP Year
2019
Awarded Amount
$41,962
Disease
Malaria
Intervention
Drug
Development Stage
Hit Identification
Collaboration Partners
Takeda Pharmaceutical Company Limited, Medicines for Malaria Venture (MMV)
Publication
- Mabrouk MT, Huang WC, Deng B, Li-Purcell N, Seffouh A, Ortega J, Ekin Atilla-Gokcumen G, Long CA, Miura K, Lovell JF. Lyophilized, antigen-bound liposomes with reduced MPLA and enhanced thermostability. Int J Pharm. 2020 Sep 2;589:119843. doi: 10.1016/j.ijpharm.2020.119843. Epub ahead of print. PMID: 32890653.